FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib

Fibroblast growth factor receptor (FGFR) gene alterations are relatively frequent in lung squamous cell carcinoma (LSCC) and are a potential targets for therapy with FGFR inhibitors. However, little is known regarding the clinicopathologic features associated with FGFR alterations. The angiokinase i...

全面介紹

Na minha lista:
書目詳細資料
發表在:Cancer Sci
Main Authors: Hibi, Masaaki, Kaneda, Hiroyasu, Tanizaki, Junko, Sakai, Kazuko, Togashi, Yosuke, Terashima, Masato, De Velasco, Marco Antonio, Fujita, Yoshihiko, Banno, Eri, Nakamura, Yu, Takeda, Masayuki, Ito, Akihiko, Mitsudomi, Tetsuya, Nakagawa, Kazuhiko, Okamoto, Isamu, Nishio, Kazuto
格式: Artigo
語言:Inglês
出版: John Wiley and Sons Inc. 2016
主題:
Original Articles
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5132273/
https://ncbi.nlm.nih.gov/pubmed/27581340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13071
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍